Outcomes of third line chemotherapy for recurrent and persistent cervical cancer

被引：0
|
作者：
Manders, D. B. [1 ]
Purinton, S. C. [1 ]
Lea, J. S. [1 ]
Miller, D. S. [1 ]
Kehoe, S. M. [1 ]
Richardson, D. L. [1 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
来源：
GYNECOLOGIC ONCOLOGY | 2011年 / 123卷 / 02期
关键词：
D O I：
10.1016/j.ygyno.2011.07.073
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：442 / 443
页数：2
相关论文
共 50 条
  • [1] Chemotherapy for recurrent or persistent cervical cancer
    O'Boyle, K
    [J]. CANCER INVESTIGATION, 2004, 22 (03) : 477 - 478
  • [2] Third-line salvage chemotherapy for recurrent cervical cancer.
    Manders, D. B.
    Purinton, S. C.
    Lea, J.
    Miller, D. S.
    Kehoe, S. M.
    Richardson, D. L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Chemotherapy in the treatment of metastatic, persistent, and recurrent cervical cancer
    Eskander, Ramez N.
    Tewari, Krishnansu S.
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2014, 26 (04) : 314 - 321
  • [4] Chemotherapy for recurrent, metastatic, or persistent cervical cancer: a systematic review
    Hirte, H. W.
    Strychowskyz, J. E.
    Oliverz, T.
    Fung-Kee-Fung, M.
    Elit, L.
    Oza, A. M.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (06) : 1194 - 1204
  • [5] ONCOLOGIC OUTCOMES OF STAGE IVB OR RECURRENT OR PERSISTENT CERVICAL CANCER PATIENTS WHO RECEIVED CHEMOTHERAPY IN THAILAND
    Ruengkhachorn, I.
    Leelaphatanadit, C.
    Hunnangkul, S.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 909 - 909
  • [6] Pembrolizumab with chemotherapy, with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer
    McNamara, Blair
    Chang, Yifan
    Mutlu, Levent
    Harold, Justin
    Santin, Alessandro D.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (03) : 227 - 233
  • [7] Chemotherapy with mitomycin c, ifosfamide, and cisplatin for recurrent or persistent cervical cancer
    Serkies, K.
    Jassem, J.
    Dziadziuszko, R.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (03) : 1152 - 1156
  • [8] Platinum-based combinations as first-line chemotherapy in advanced, persistent, or recurrent cervical cancer.
    Limareva, Svetlana Vladimirovna
    Khokhlova, Svetlana Victorovna
    Odintsova, Anastasiya Sergeevna
    Cherkasova, Marina Valerievna
    Vinogradova, Liliya Igorevna
    Gorbunova, Vera A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Clinical outcomes of patients with recurrent small cell lung cancer receiving third-line chemotherapy
    Saruwatari, Koichi
    Umemura, Shigeki
    Nomura, Shogo
    Matsumoto, Shingo
    Yoh, Kiyotaka
    Niho, Seiji
    Goto, Koichi
    Ohmatsu, Hironobu
    Ohe, Yuichiro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] A pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancer
    Cetina, Lucely
    Crombet, Tania
    Jimenez-Lima, Roberto
    Zapata, Sergio
    Ramos, Mayra
    Avila, Sandra
    Coronel, Jaime
    Charco, Eduardo
    Bojalil, Rafael
    Astudillo, Horacio
    Bazan, Blanca
    Duenas-Gonzalez, Alfonso
    [J]. CANCER BIOLOGY & THERAPY, 2015, 16 (05) : 684 - 689
12345